RecruitingNot ApplicableNCT05527652

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Sponsor

University of Michigan

Enrollment

40 participants

Start Date

Nov 16, 2022

Study Type

INTERVENTIONAL

Conditions

Obstructive Sleep Apnea Down Syndrome Tolerance Trisomy 21 Hypertonia, Muscle Nasal Airway Obstruction

Summary

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

Eligibility

Min Age: 3 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Self-Supporting Nasopharyngeal Airway (ssNPA) for people with down syndrome, hypertonia, muscle, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESelf-Supporting Nasopharyngeal Airway (ssNPA)

The ssNPA device is made of a single piece of flexible, medical-grade silicone. It is inserted through one nostril and extends to the anatomic position bypassing the upper airway obstruction above the epiglottis.